Lv51
1033 积分 2025-12-26 加入
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial
35分钟前
待确认
Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism
8天前
已完结
Herb-Growing in the British Empire
10天前
已完结
Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up
1个月前
已完结
Developing clinical prediction models: a step-by-step guide
1个月前
已完结
Building Predictive Models in R Using the caret Package
1个月前
已完结
The comparative efficacy of 12-mo of alendronate and raloxifene in maintaining denosumab-induced improvement in peripheral volumetric BMD, microarchitecture, and estimated strength
1个月前
已完结
Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses
1个月前
已完结
The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension
1个月前
已完结
Impact of denosumab on muscle health in older adults in long-term care
1个月前
已完结
皖公网安备34019202002308
